NOVEL COMBINATION OF NON SEDATIVE ANTI HISTAMINES CONTAINING SUBSTANCES WHICH INFLUENCE THE ACTION OF LEUKOTRIENE, FOR TREATING RHINITIS CONJUNCTIVITIS.

摘要

The invention relates to a pharmaceutical combination to be administered topically or orally of a non sedative anti histamine, with the exception of compounds of the loratadine type, and a leukotriene antagonist, selected from a leukotriene D4 antagonist, or a 5 lipoxygenase inhibitor, or a FLAP antagonist and optionally conventional, physiologically harmless supports, extenders and auxiliary agents, for the prophylaxis and treatment of allergic and or vasomotor rhinitis or allergic conjunctivitis.